HIV Diagnosis & Treatment Market
HIV Diagnosis & Treatment Market Size and Growth
The HIV Diagnosis & Treatment market is expanding due to increasing prevalence, advancements in technology, and comprehensive healthcare policies. The market size was valued at approximately $28 billion in 2022, with a projected growth rate of 5.7% CAGR through 2030. Emerging therapies and improved diagnostics drive innovation and accessibility.
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Laboratories
◍ Boehringer Ingelheim
◍ Bristol-Myers Squibb
◍ Cipla
◍ F. Hoffmann-La Roche
◍ Gilead
◍ GlaxoSmithKline
◍ Johnson & Johnson
The HIV Diagnosis & Treatment Market features key players like Abbott Laboratories, Gilead, and Johnson & Johnson, innovating diagnostics and therapies. These companies expand market access through R&D, strategic partnerships, and affordable solutions. For instance, Gilead reported sales of approximately $26 billion in 2022, driving growth in the sector. Request Sample Report
Market Segmentation
By Application
Hospitals
Clinics
Request Sample Report
By Product
ELISA Test
Saliva Tests
Viral Load Test
Western Blot
Others
Market Growth
Request Sample Report
$ X Billion USD
